EMA restrict pembrolizumab/atezolizumab usage in urothelial cancer
Combination and monotherapies in NSCLC
Phase 1 clinical trial focused on safety of probiotics in cancer patients with mucositis
Vinflunine shows a chemotherapeutic advantage for locally-advanced and metastatic penile cancer
How can durvalumab be used in NSCLC?